FGF21 and hydrops fetalis: FGF21 may also mediate the effects of SGLT2 inhibitors on body weight reduction and lipolysis in adipose tissue and contribute, at least in part, to the reduction in all-cause and cardiovascular mortality in HF patients [91, 92].